MIR7851: A Potential Drug Target and Biomarker for Cancer (G102467003)
MIR7851: A Potential Drug Target and Biomarker for Cancer
MicroRNA 7851 (MIR7851) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for several diseases, including cancer. MIR7851 is a key regulator of the cell cycle, and its expression is regulated by several factors, including microtubules, kinetin, and p53. MIR7851 has been shown to play a role in the regulation of cell division, and its levels have been linked to the outcomes of several cancer types, including breast, ovarian, and colorectal cancers.
The discovery of MIR7851 as a potential drug target and biomarker for cancer has significant implications for the development of new treatments. MIR7851 has been shown to be involved in the regulation of cell division, which is a critical process for the growth and survival of cancer cells. By targeting MIR7851, researchers may be able to disrupt the cell cycle and inhibit the growth and survival of cancer cells.
In addition to its potential as a drug target, MIR7851 has also been identified as a potential biomarker for cancer. The expression of MIR7851 has been shown to be associated with the outcomes of several cancer types, including breast, ovarian, and colorectal cancers. By detecting MIR7851 levels in cancer samples or fluids, researchers may be able to use MIR7851 as a diagnostic or predictive marker for cancer diagnosis or prognosis.
The identification of MIR7851 as a potential drug target and biomarker for cancer has been the result of a collaborative effort between several research groups. The MIR7851 gene was first identified through a genomic screening experiment, and subsequent studies have shown that MIR7851 is involved in the regulation of cell cycle progression and has been shown to play a role in the regulation of cell division.
In addition to its potential as a drug target and biomarker, MIR7851 has also been shown to have several potential therapeutic applications. For example, MIR7851 has been shown to inhibit the growth of cancer cells in cell culture, and may be an effective agent for the treatment of cancer. In addition, MIR7851 has been shown to interact with several other molecules, including the transcription factor p21, which may influence its function in the regulation of cell growth and division.
The potential drug targeting of MIR7851 is an exciting area of research, and further studies are needed to fully understand its effects and potential as a drug. MIR7851 has been shown to be involved in the regulation of cell cycle progression, which is a critical process for the growth and survival of cancer cells. By targeting MIR7851, researchers may be able to disrupt the cell cycle and inhibit the growth and survival of cancer cells. Additionally, MIR7851 has been shown to have several potential therapeutic applications, and further studies are needed to fully understand its effects in the treatment of cancer.
Protein Name: MicroRNA 7851
More Common Targets
MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055 | MIR8059 | MIR8060 | MIR8061 | MIR8063 | MIR8064 | MIR8067 | MIR8069-1 | MIR8070 | MIR8071-1 | MIR8071-2 | MIR8072 | MIR8073 | MIR8075 | MIR8076 | MIR8078 | MIR8080 | MIR8082 | MIR8084 | MIR8085 | MIR8087 | MIR8088 | MIR8089 | MIR8485 | MIR873 | MIR874 | MIR875 | MIR876 | MIR877 | MIR885 | MIR887 | MIR888 | MIR889 | MIR890 | MIR891A | MIR891B | MIR892A | MIR892B | MIR892C | MIR9-1 | MIR9-1HG | MIR9-2 | MIR9-3 | MIR9-3HG | MIR920 | MIR921 | MIR922 | MIR924 | MIR924HG | MIR92A1 | MIR92A2 | MIR92B | MIR93 | MIR933 | MIR934 | MIR935 | MIR936 | MIR937 | MIR938 | MIR939 | MIR940 | MIR941-1 | MIR941-2 | MIR941-3 | MIR941-4 | MIR941-5 | MIR942 | MIR943 | MIR944 | MIR95 | MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A
